We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J Unit Seeks Kirkland's Pfizer Docs In Antitrust Fight

Law360 (June 11, 2019, 6:59 PM EDT) -- A Johnson & Johnson subsidiary has asked a New York federal court to order Kirkland & Ellis to produce documents in a Pennsylvania antitrust dispute with Pfizer related to J&J’s blockbuster drug Remicade, arguing the documents have already been handed over in another suit between the two companies.

J&J and Janssen Biotech told the New York court in a petition filed Monday that the documents it was seeking related to the approval, pricing and marketing of Pfizer’s drug Inflectra, which is a biosimilar of Remicade, and that the documents were not privileged.

Moreover, J&J argued, to get the documents directly from...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

New York Southern

Nature of Suit

Date Filed

June 10, 2019

Law Firms

Companies

Government Agencies